Dimerized Translationally Controlled Tumor Protein-Binding Peptide 2 Attenuates Systemic Anaphylactic Reactions Through Direct Suppression of Mast Cell Degranulation
Dimerized translationally controlled tumor protein (dTCTP) amplifies allergic responses through activation of several types of immune cells and release of inflammatory mediators. In particular, dTCTP plays an important role in histamine release by triggering mast cells and has been proposed as a tar...
Main Authors: | Hyunsoo Cho, Jiyoung Park, Hyo Kyeong Kim, Eun Sook Hwang, Kyunglim Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-10-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.764321/full |
Similar Items
-
dTBP2 attenuates severe airway inflammation by blocking inflammatory cellular network mediated by dTCTP
by: Hyunsoo Cho, et al.
Published: (2021-12-01) -
PEGylation improves the therapeutic potential of dimerized translationally controlled tumor protein blocking peptide in ovalbumin-induced mouse model of airway inflammation
by: Hyeran Seo, et al.
Published: (2022-12-01) -
Dimeric translationally controlled tumor protein–binding peptide 2 attenuates imiquimod-induced psoriatic inflammation through induction of regulatory T cells
by: Hyunsoo Cho, et al.
Published: (2022-08-01) -
Dimerized Translationally Controlled Tumor Protein-Binding Peptide Ameliorates Atopic Dermatitis in NC/Nga Mice
by: Xing-Hai Jin, et al.
Published: (2017-01-01) -
Safranal Alleviated OVA-Induced Asthma Model and Inhibits Mast Cell Activation
by: Peeraphong Lertnimitphun, et al.
Published: (2021-05-01)